Related references
Note: Only part of the references are listed.The 1988 US Surgeon General's report Nicotine Addiction: how well has it stood up to three more decades of research?
Robert West et al.
ADDICTION (2022)
The involvement of mesolimbic dopamine system in cotinine self-administration in rats
Xiaoying Tan et al.
BEHAVIOURAL BRAIN RESEARCH (2022)
Effects of transdermal nicotine delivery on cognitive outcomes: A meta-analysis
Alireza Majdi et al.
ACTA NEUROLOGICA SCANDINAVICA (2021)
Cotinine: Pharmacologically Active Metabolite of Nicotine and Neural Mechanisms for Its Actions
Xiaoying Tan et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2021)
EEG as a Functional Marker of Nicotine Activity: Evidence From a Pilot Study of Adults With Late-Life Depression
Alexander C. Conley et al.
FRONTIERS IN PSYCHIATRY (2021)
Ferulic Acid Ameliorates Alzheimer's Disease-like Pathology and Repairs Cognitive Decline by Preventing Capillary Hypofunction in APP/PS1 Mice
Ni-Ya Wang et al.
NEUROTHERAPEUTICS (2021)
Nicotine and Cognition in Cognitively Normal Older Adults
Olivia Nop et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Tobacco and Nervous System Development and Function-New Findings 2015-2020
Wojciech Hajdusianek et al.
BRAIN SCIENCES (2021)
What lessons have we learnt about the impact of maternal cigarette smoking from animal models?
Yik L. Chan et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2020)
Neuroprotective Effects of Quercetin in Alzheimer's Disease
Haroon Khan et al.
BIOMOLECULES (2020)
Scopoletin ameliorates anxiety-like behaviors in complete Freund's adjuvant-induced mouse model
Li Luo et al.
MOLECULAR BRAIN (2020)
Neuroprotective Effects of D-(-)-Quinic Acid on Aluminum Chloride-Induced Dementia in Rats
Lu Liu et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Neuroprotective Effect of Chlorogenic Acid on Mitochondrial Dysfunction-Mediated Apoptotic Death of DA Neurons in a Parkinsonian Mouse Model
Saumitra Sen Singh et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
beta-Asarone improves learning and memory in A beta(1-42)-induced Alzheimer's disease rats by regulating PINK1-Parkin-mediated mitophagy
Yufeng Han et al.
METABOLIC BRAIN DISEASE (2020)
Neuroprotective potential of solanesol in a combined model of intracerebral and intraventricular hemorrhage in rats
Kajal Rajdev et al.
IBRO REPORTS (2020)
β-Carbolines found in cigarette smoke elevate intracranial self-stimulation thresholds in rats
Andrew C. Harris et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Antidepressants for smoking cessation
Seth Howes et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
Preventive Effect of Quercetin in a Triple Transgenic Alzheimer's Disease Mice Model
Perez-Corredor Paula et al.
MOLECULES (2019)
Neuroprotective Effects of Limonene (+) against Aβ42-Induced Neurotoxicity in a Drosophila Model of Alzheimer’s Disease
Myeongcheol Shin et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2019)
High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study
G. Villafane et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
In vitro neuroprotective effects of naringenin nanoemulsion against β-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation
Shadab Md et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Nicotine normalizes cortico-striatal connectivity in non-smoking individuals with major depressive disorder
Amy C. Janes et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression
Jason A. Gandelman et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Potential Roles of microRNAs in the Regulation of Monoamine Oxidase A in the Brain
Yuki Higuchi et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Evidence of a Causal Relationship Between Smoking Tobacco and Schizophrenia Spectrum Disorders
James G. Scott et al.
FRONTIERS IN PSYCHIATRY (2018)
Combined application of tenuigenin and β-asarone improved the efficacy of memantine in treating moderate-to-severe Alzheimer's disease
Wenguang Chang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Nicotine self-administration reverses cognitive deficits in a rat model for schizophrenia
Uta Waterhouse et al.
ADDICTION BIOLOGY (2018)
The Association of Cigarette Smoking With Depression and Anxiety: A Systematic Review
Meg Fluharty et al.
NICOTINE & TOBACCO RESEARCH (2017)
Tobacco's minor alkaloids: Effects on place conditioning and nucleus accumbens dopamine release in adult and adolescent rats
Julie A. Marusich et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Diseases
Edilio Borroni et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
CHRONIC NICOTINE ATTENUATES BEHAVIORAL AND SYNAPTIC PLASTICITY IMPAIRMENTS IN A STREPTOZOTOCIN MODEL OF ALZHEIMER'S DISEASE
I. M. Esteves et al.
NEUROSCIENCE (2017)
Rutin alleviates chronic unpredictable stress-induced behavioral alterations and hippocampal damage in mice
Arun Parashar et al.
NEUROSCIENCE LETTERS (2017)
Monoamine oxidase inhibitory activity in tobacco particulate matter: Are harman and norharman the only physiologically relevant inhibitors?
Penelope Truman et al.
NEUROTOXICOLOGY (2017)
Smoking and age-at-onset of both motor and non-motor symptoms in Parkinson's disease
Angelo Fabio Gigante et al.
PARKINSONISM & RELATED DISORDERS (2017)
Anxiety and Nicotine Dependence: Emerging Role of the Habenulo-Interpeduncular Axis
Susanna Molas et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Slow-release L-Cysteine (Acetium (R)) Lozenge Is an Effective New Method in Smoking Cessation. A Randomized, Double-blind, Placebo-controlled Intervention
Kari Syrjanen et al.
ANTICANCER RESEARCH (2017)
Nicotine slows down oligomerisation of α-synuclein and ameliorates cytotoxicity in a yeast model of Parkinson's disease
Jay Kardani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Tobacco smoking: Health impact, prevalence, correlates and interventions
Robert West
PSYCHOLOGY & HEALTH (2017)
The separate and combined effects of monoamine oxidase A inhibition and nicotine on resting state EEG
Dylan M. Smith et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence
Ron C. Hogg
NICOTINE & TOBACCO RESEARCH (2016)
Vanillin Attenuated Behavioural Impairments, Neurochemical Deficts, Oxidative Stress and Apoptosis Against Rotenone Induced Rat Model of Parkinson's Disease
Chinnasamy Dhanalakshmi et al.
NEUROCHEMICAL RESEARCH (2016)
Effects of Monoamine Oxidase Inhibition on the Reinforcing Properties of Low-Dose Nicotine
Tracy T. Smith et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Lipopolysaccharide induced anxiety- and depressive-like behaviour in mice are prevented by chronic pre-treatment of esculetin
Kunjbihari Sulakhiya et al.
NEUROSCIENCE LETTERS (2016)
Neuroprotective effect of beta-asarone against Alzheimer's disease: regulation of synaptic plasticity by increased expression of SYP and GluR1
Si-jun Liu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Monoamine Oxidase Inhibitors Extracted from Tobacco Smoke as Neuroprotective Factors for Potential Treatment of Parkinson's Disease
Youssef Sari et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
Effects of nicotine and minor tobacco alkaloids on intracranial-self-stimulation in rats
Andrew C. Harris et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Effects of MAO inhibition and a combination of minor alkaloids, β-carbolines, and acetaldehyde on nicotine self-administration in adult male rats
Tracy T. Smith et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Does cigarette smoking relieve stress? Evidence from the event-related potential (ERP)
Damee Choi et al.
INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY (2015)
Tobacco particulate matter self-administration in rats: differential effects of tobacco type
Katharine A. Brennan et al.
ADDICTION BIOLOGY (2015)
Antidepressant-like effects of ferulic acid: involvement of serotonergic and norepinergic systems
Jianliang Chen et al.
METABOLIC BRAIN DISEASE (2015)
Effect of naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of rats
Wenqing Yang et al.
NEUROLOGICAL SCIENCES (2014)
Reinforcing and neural activating effects of norharmane, a non-nicotine tobacco constituent, alone and in combination with nicotine
Monica M. Arnold et al.
NEUROPHARMACOLOGY (2014)
Comparison of the Reinforcing Properties of Nicotine and Cigarette Smoke Extract in Rats
Matthew R. Costello et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Naringin ameliorates memory deficits in experimental paradigm of Alzheimer's disease by attenuating mitochondrial dysfunction
Anand Kamal Sachdeva et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Behavioural, neurochemical and neuroendocrine effects of the endogenous β-carboline harmane in fear-conditioned rats
Karen L. Smith et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat
D. H. Malin et al.
LIFE SCIENCES (2013)
How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways
Steven Moylan et al.
BRAIN AND BEHAVIOR (2013)
Smoking, quitting, and psychiatric disease: A review
Henri-Jean Aubin et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2012)
Antidepressant-like behavioral, neurochemical and neuroendocrine effects of naringenin in the mouse repeated tail suspension test
Li-Tao Yi et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Tobacco Branding, Plain Packaging, Pictorial Warnings, and Symbolic Consumption
Janet Hoek et al.
QUALITATIVE HEALTH RESEARCH (2012)
Naturally-expressed nicotinic acetylcholine receptor subtypes
Jie Wu et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Neuroprotective Effect of Kaempferol against a 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease
Shen Li et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Serotonergic Mechanism Underlying Tranylcypromine Enhancement of Nicotine Self-Administration
Anne-Sophie Villegier et al.
SYNAPSE (2011)
Can nicotine be used medicinally in Parkinson’s disease?
Claire Thiriez et al.
Expert Review of Clinical Pharmacology (2011)
Catechol derivatives inhibit the fibril formation of amyloid-beta peptides
Vu Thi Huong et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2010)
Smoking, nicotine and neuropsychiatric disorders
Peter Dome et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
Nicotine Addiction
Neal L. Benowitz
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Comparison of the behavioral effects of cigarette smoke and pure nicotine in rats
Andrew C. Harris et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics
Neal L. Benowitz
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2009)
Smoking and Parkinson's disease: Does nicotine affect α-synuclein fibrillation?
Dong-Pyo Hong et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys
Luping Z. Huang et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
Edson X. Albuquerque et al.
PHYSIOLOGICAL REVIEWS (2009)
Naphthoquinones and Bioactive Compounds from Tobacco as Modulators of Neuronal Nitric Oxide Synthase Activity
Priya Venkatakrishnan et al.
PHYTOTHERAPY RESEARCH (2009)
Smoking Induces Long-Lasting Effects through a Monoamine-Oxidase Epigenetic Regulation
Jean-Marie Launay et al.
PLOS ONE (2009)
Actions of octocoral and tobacco cembranoids on nicotinic receptors
P. A. Ferchmin et al.
TOXICON (2009)
Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells
Karen Riveles et al.
NEUROTOXICOLOGY (2008)
Monoamine oxidase inhibition for tobacco pharmacotherapy
T. P. George et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Role of acetaldehyde in tobacco smoke addiction
Reinskje Talhout et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
Monoamine oxidase and tobacco dependence
A. Lewis et al.
NEUROTOXICOLOGY (2007)
Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine
Anne-Sophie Villegier et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Antidepressant-like effect of harmane and other β-carbolines in the mouse forced swim test
Davood Farzin et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Nicotine attenuates β-amyloid-induced neurotoxicity by regulating metal homeostasis
Jie Zhang et al.
FASEB JOURNAL (2006)
Nicotine and nonnicotine factors in cigarette addiction
JE Rose
PSYCHOPHARMACOLOGY (2006)
A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia
P Postma et al.
PSYCHOPHARMACOLOGY (2006)
Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats
K Guillem et al.
JOURNAL OF NEUROSCIENCE (2005)
Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats
JD Belluzzi et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Metabolism and disposition kinetics of nicotine
J Hukkanen et al.
PHARMACOLOGICAL REVIEWS (2005)
Cue reactivity in nicotine and tobacco dependence: a multiple-action model of nicotine as a primary reinforcement and as an enhancer of the effects of smoking-associated stimuli
C Chiamulera
BRAIN RESEARCH REVIEWS (2005)
Human monoamine oxidase is inhibited by tobacco smoke:: β-carboline alkaloids act as potent and reversible inhibitors
T Herraiz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Effects of nicotinic stimulation on cognitive performance
PA Newhouse et al.
CURRENT OPINION IN PHARMACOLOGY (2004)
The neurobiology of nicotine addiction: Bridging the gap from molecules to behaviour
SR Laviolette et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: Occurrence, metabolism and function in human brains
M Naoi et al.
NEUROTOXICOLOGY (2004)
Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; Are there links?
K Castagnoli et al.
NEUROTOXICOLOGY (2004)
Eugenol exhibits antidepressant-like activity in mice and induces expression of metallothionein-III in the hippocampus
Y Irie et al.
BRAIN RESEARCH (2004)
Nicotine and nicotinic receptor involvement in neuropsychiatric disorders
P Newhouse et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Extracts from 'BestTreatments - Treating nicotine addiction
A Jain
BRITISH MEDICAL JOURNAL (2003)
A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation
R Biberman et al.
ADDICTION (2003)
Treatment of adolescent tobacco smokers: issues and opportunities for exposure reduction approaches
ET Moolchan et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
Acetaldehyde in mainstream tobacco smoke: Formation and occurrence in smoke and bioavailability in the smoker
JI Seeman et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2002)
Modulation of nicotinic receptor activity in the central nervous system: A novel approach to the treatment of Alzheimer disease
EX Albuquerque et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2001)
Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus
M Alkondon et al.
NEUROPHARMACOLOGY (2000)
Share Paper
